Wela Strategies’s Zymeworks ZYME Stock Holding History

Wela Strategies’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-70,255	Closed	-$445K	–	50
2023 Q3	$445K	Buy	70,255 +39,531	+129%	+$292K	0.27%	31
2023 Q2	$265K	Buy	30,724 +14,830	+93%	+$133K	0.2%	37
2023 Q1	$144K	Buy	+15,894	New	+$139K	0.08%	45
2022 Q4	–	Sell	-14,796	Closed	-$91K	–	46
2022 Q3	$91K	Hold	14,796	–	–	0.06%	44
2022 Q2	$78K	Buy	+14,796	New	+$89.5K	0.05%	44

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wela Strategies's ZYME Position: Q4 2023 in Review

Wela Strategies sold out of Zymeworks (ZYME) in Q4 2023, closing a stake of 70,255 shares — an estimated $445K sold.

Wela Strategies first reported a position in ZYME in Q2 2022 and held it in 5 quarters. The position peaked at $445K in Q3 2023. 157 funds tracked by Wall St. Rank hold ZYME as of Q4 2023.

Wela Strategies reported no remaining Zymeworks position as of Q4 2023 after selling out during the quarter.
Wela Strategies sold 70,255 Zymeworks shares in Q4 2023, an estimated $445K.
Wela Strategies first reported a position in Zymeworks in Q2 2022 and held it in 5 quarters.
Wela Strategies's Zymeworks position peaked at $445K in Q3 2023.
157 funds tracked by Wall St. Rank held Zymeworks as of Q4 2023.

Based on Wela Strategies's 13F filing for Q4 2023, filed 5 Jan 2024.